Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
Clinical management of advanced gastric cancer: The role of new molecular drugs
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ferdinando De Vita, Natale Di Martino, Alessio Fabozzi, Maria Maddalena Laterza, Jole Ventriglia, Beatrice Savastano, Angelica Petrillo, Valentina Gambardella, Vincenzo Sforza, Luigi Marano, Annamaria Auricchio, Gennaro Galizia, Fortunato Ciardiello and Michele Orditura |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Ferdinando De Vita, MD, PhD, Assistant Professor of Oncology, Division of Medical Oncology, Department of Clinical and Experimental Medicine and Surgery, Second University of Naples School of Medicine, c/o Ⅱ Policlinico, Edificio 3, Via Pansini 5, 80131 Naples, Italy. ferdinando.devita@unina2.it |
Key Words |
Advanced gastric cancer; Gastrointestinal cancer; Targeted therapy; Monoclonal antibodies; Tyrosine-kinase inhibitor; Gastric cancer |
Core Tip |
In this article we review the actual “scenario” of targeted treatments in advanced gastric cancer, also focusing on the new agents in development,discussing their efficacy and potential applications in clinical practice. |
Publish Date |
2014-10-29 19:34 |
Citation |
De Vita F, Di Martino N, Fabozzi A, Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V, Sforza V, Marano L, Auricchio A, Galizia G, Ciardiello F, Orditura M. Clinical management of advanced gastric cancer: The role of new molecular drugs. World J Gastroenterol 2014; 20(40): 14537-14558 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i40/14537.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i40.14537 |